Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 5
Submit an article Journal homepage
334
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

A case of acute myeloid leukemia with unusual germline CEBPA mutation: lessons learned about mutation detection, location, and penetrance

Hadrian Mendozaa Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USAORCID Iconhttps://orcid.org/0000-0002-0040-6583View further author information
ORCID Icon,
Po-Han Chena Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA;b Department of Pathology, Yale School of Medicine, New Haven, CT, USAView further author information
,
Alexander B. Pinec Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAORCID Iconhttps://orcid.org/0000-0002-9463-3022View further author information
ORCID Icon,
Alexa J. Siddona Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA;b Department of Pathology, Yale School of Medicine, New Haven, CT, USAView further author information
,
Allen E. Baled Department of Genetics, Yale School of Medicine, New Haven, CT, USAView further author information
,
Lohith Gowdac Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USAView further author information
,
Amy Killiee Smilow Cancer Genetics and Prevention Program, Yale-New Haven Health, New Haven, CT, USAView further author information
,
Jonica Richardse Smilow Cancer Genetics and Prevention Program, Yale-New Haven Health, New Haven, CT, USAView further author information
,
Camille Varin-Tremblaye Smilow Cancer Genetics and Prevention Program, Yale-New Haven Health, New Haven, CT, USAView further author information
,
Robert Klossf Section of Hematology-Oncology, Danbury Hospital, Danbury, CT, USAView further author information
&
Nikolai A. Podoltsevc Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3657-778XView further author information
ORCID Icon show all
Pages 1251-1254 | Received 09 Oct 2020, Accepted 29 Nov 2020, Published online: 19 Dec 2020

References

  • Taskesen E, Bullinger L, Corbacioglu A, et al. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood. 2011;117(8):2469–2475.
  • Green CL, Koo KK, Hills RK, et al. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. J Clin Oncol. 2010;28(16):2739–2747.
  • Pabst T, Eyholzer M, Haefliger S, et al. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. J Clin Oncol. 2008;26(31):5088–5093.
  • Grossmann V, Schnittger S, Schindela S, et al. Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technology. J Mol Diagn. 2011;13(2):129–136.
  • Tawana K, Wang J, Renneville A, et al. Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood. 2015;126(10):1214–1223.
  • Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27(3):263–270.
  • Smith ML, Cavenagh JD, Lister TA, et al. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med. 2004;351(23):2403–2407.
  • Godley LA, Shimamura A. Genetic predisposition to hematologic malignancies: management and surveillance. Blood. 2017;130(4):424–432.
  • Ram J, Flamm G, Balys M, et al. Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation. Blood Adv. 2017;1(8):500–503.
  • Pathak A, Seipel K, Pemov A, et al. Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family. Haematologica. 2016;101(7):846–852.
  • Rio-Machin A, Vulliamy T, Hug N, et al. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants. Nat Commun. 2020;11(1):1044.
  • DiNardo CD. Getting a handle on hereditary CEBPA mutations. Blood. 2015;126(10):1156–1158.
  • Ng CWS, Kosmo B, Lee PL, et al. CEBPA mutational analysis in acute myeloid leukaemia by a laboratory-developed next-generation sequencing assay. J Clin Pathol. 2018;71(6):522–531.
  • Xiao H, Shi J, Luo Y, et al. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2011;117(19):5257–5260.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.